Author: Cody Micah Carmichael MPH, CPH

MMWR Booster for: Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022, Weekly / December 9, 2022 / 71(49);1560–1564

Posted on January 6, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: Significantly Lower Incidence in Vaccinated Individuals: The study found that mpox incidence among unvaccinated individuals was 9.6 times higher than among those who received two doses of

MMWR Booster for: Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2021–September 2022, Weekly / December 9, 2022 / 71(49);1541–1546

Posted on January 6, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Reduction in Polio Cases: Afghanistan reported only two cases of wild poliovirus type 1 (WPV1) in 2022 up to September, a reduction from previous years, with no

MMWR Booster for: Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season, Weekly / December 16, 2022 / 71(50);1589–1596

Posted on January 5, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways 6% of pediatric influenza hospitalizations had concurrent SARS-CoV-2 (COVID) coinfection during the 2021–22 influenza season. Coinfected patients exhibited a higher need for respiratory support (invasive or noninvasive)

MMWR Booster for: Notes from the Field: Seizures, Hyperthermia, and Myocardial Injury in Three Young Adults Who Consumed Bromazolam Disguised as Alprazolam — Chicago, Illinois, February 2023, Weekly / January 5, 2024 / 72(5253);1392–1393

Posted on January 5, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways 1. Bromazolam Might Be Sold as Benzodiazepines: Identified as a counterfeit benzodiazepine, bromazolam use has increased, often found in combination with fentanyl. 2. Severe Health Impacts: Three

MMWR Booster for: Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months — California, January–March, 2023. Weekly / January 5, 2024 / 72(5253);1390–1391

Posted on January 5, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Recurrent Drug Shortages: The U.S., particularly California, has faced recurring shortages of first- and second-line TB drugs, impacting treatment regimens. High Priority Concern: California TB programs rated

MMWR Booster for: Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells — United States, 2023, January 5, 2024 / 72(5253);1385–1389

Posted on January 5, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Second Outbreak in Recent Years: This report covers the second outbreak of TB related to bone allografts in recent years, with 36 recipients affected. Initial Detection and

MMWR Booster for: COVID-19 and Other Underlying Causes of Cancer Deaths — United States, January 2018–July 2022, Weekly / December 16, 2022 / 71(50);1583–1588

Posted on January 5, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: Increased Risk for Cancer Patients: Individuals with cancer showed an elevated risk of dying from COVID-19, with 2.0% in 2020 and 2.4% in 2021 having COVID-19 as

MMWR Booster for: Drug Overdose Deaths Among Persons Aged 10–19 Years — United States, July 2019–December 2021, Weekly / December 16, 2022 / 71(50);1576–1582

Posted on January 4, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: Median monthly overdose deaths among adolescents aged 10-19 years increased by 109% from July–December 2019 to July–December 2021. Deaths involving illicitly manufactured fentanyls (IMFs) rose by 182%,

MMWR Booster for: Progress Toward Measles and Rubella Elimination — India, 2005–2021, Weekly / December 16, 2022 / 71(50);1569–1575

Posted on January 4, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Increased Vaccine Coverage: From 2005 to 2021, coverage with the first dose of a measles-containing vaccine (MCV) increased from 68% to 89%, and the second dose from

MMWR Booster for: Notes from the Field: Clinical and Epidemiologic Characteristics of Mpox Cases from the Initial Phase of the Outbreak — New York City, May 19–July 15, 2022, Weekly / December 30, 2022 / 71(5152);1631–1633

Posted on January 3, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: Demographics and Risk Behaviors: Among 719 mpox patients in NYC, 97.9% were men, predominantly identifying as gay or queer (78.7%), or bisexual (5.6%). A significant proportion reported